CUR - 1.71 Pre-market now at 2.00/2.05 Neuralstem Announces First Surgery Completed in Cervical Cohort of Phase 1 Clinical Trial in Patients with Chronic Spinal Cord Injury http://stockcharts.com/c-sc/sc?s=CUR&p=D&b=5&g=0&i=t86474200507&r=1523362062532 http://stockcharts.com/c-sc/sc?s=CUR&p=W&b=5&g=0&i=t24707251824&r=1523362094399